METHYL FURO[3,2-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 250mg

[(1-methyl-1H-pyrrol-2-yl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

2-(3,4,5-trimethoxyphenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine, 95.0%, 1g

4-Hydroxy-2-nitrobenzoic acid, 95.0%, 5g

2-(4-(Benzyloxy)-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

3-(4-Benzyloxy-3-methoxy-phenyl)-propionic acid ethyl ester, 97%, 500mg

1,3-Bis(trifluoromethyl)cyclohexane (cis- and trans- mixture)>98.0%(GC)5g

2-BROMO-4-METHOXYBENZO[D]THIAZOLE, 95.0%, 1g

3-Methyloxetan-3-ol, 95.0%, 25g

Dihydrolinalool>95.0%(GC)500mL

Solution d'hydroxyde de sodium, ROTI®Volum 1 mol/l - 1 N, ampoule, 1 pièce, emballage plastique.

2-ACETAMIDOBENZYL ALCOHOL, 97.0%, 10g

5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dithione, 95%, 1g